Lutetium-177 (¹⁷⁷Lu)

A well-established isotope for peptide receptor radionuclide therapy (PRRT), widely used in treating neuroendocrine tumors and prostate cancer. We provide high-purity Lu-177 to support therapeutic and diagnostic workflows.

Availability Production status of isotope, categorized under one of the following:

Lu-177 Routinely available: produced according to set schedules or according to current demand/requests.

For more details please contact: export@mdcr.ru